Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)
Clinical trial NCT06159478 · RECRUITING
Trial details
- NCT number
- NCT06159478
- Sponsor
- National Cancer Center, Japan
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2027-02-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.